Dermatomyositis
About one in 100,000 people are newly diagnosed each year, and the condition most often appears in people in their 40s and 50s.[1] Women are affected twice as often as men, according to the NORD report.[2] Dermatomyositis is a systemic autoimmune inflammatory condition that mainly targets the skin and skeletal muscles, characterized by a skin rash and progressive muscle weakness that worsens over time.[3]
Quick Facts
- First described
- 1800s
- Typical age of onset
- 40s and 50s
- Key autoantibodies
- myositis-specific autoantibodies (MSAs)
Facts from the source article.
Key facts and history
The NORD report notes that skin abnormalities may precede muscle weakness in up to 40% of people.[2] A distinctive reddish-purple rash on the upper eyelids, known as a heliotrope rash, is a characteristic skin finding.[2] Gottron's papules, which are red or violet scaly bumps on the finger joints, are another form of the rash.[4] The Merck Manual states that dystrophic calcification is a unique feature of dermatomyositis, occurring in juveniles and less commonly in adults.[5]
Muscle weakness progressively affects the proximal muscles, making tasks like standing from sitting and climbing stairs difficult.[6] Interstitial lung disease is a primary cause of respiratory failure in dermatomyositis, especially in patients with anti-MDA5 autoantibodies.[7] The NORD report indicates that malignancy-associated dermatomyositis appears more frequently in people over age 40-50.[2] Inherited genetic factors, including HLA subtypes HLA-DR3, HLA-DR52, and HLA-DR6, predispose individuals to developing the disease.[8]
The earliest known descriptions of this condition date back to the 1800s.[1]
What the research sources say
The NORD report states that dermatomyositis is thought to be an autoimmune disorder where the immune system inappropriately attacks the body's own tissues.[2] The Merck Manual describes dermatomyositis as characterized by immune complex deposition in vessels and considered a complement-mediated vasculopathy.[5] The NORD report notes that certain infectious agents, including coxsackievirus and parvovirus, have been suggested as potential triggers.[2] According to the Merck Manual, the cause appears to be an autoimmune reaction to muscle tissue in genetically susceptible people.[5]
The NORD report mentions that some studies have shown plaque accumulation in the arteries (atherosclerosis) in people with dermatomyositis.[2] The Merck Manual states that characteristic skin changes can occur in the absence of muscle disease, a condition called amyopathic dermatomyositis.[5]
References
- Wikipedia, "Dermatomyositis" (CC BY-SA 4.0), which cites: "Dermatomyositis", NORD (National Organization for Rare Disorders), 2015; "Dermatomyositis", NORD (National Organization for Rare Disorders), 2015; "Dermatomyositis", NORD (National Organization for Rare Disorders), 2015; "Dermatomyositis", 2009, p. 5–8 (we also read that source) en.wikipedia.org
- "Dermatomyositis", NORD (National Organization for Rare Disorders), 2015. facts only, no text reused. rarediseases.org
- Wikipedia, "Dermatomyositis" (CC BY-SA 4.0), which cites: Selva-O'Callaghan, "Classification and management of adult inflammatory myopathies", The Lancet. Neurology, September 2018, p. 816–828; Allenbach, "Inflammatory Myopathies", New England Journal of Medicine, 14 May 2026, p. 1925–1938 (original not read by us) en.wikipedia.org
- Wikipedia, "Dermatomyositis" (CC BY-SA 4.0), which cites: "Cutaneous manifestations of dermatomyositis and their management", Current Rheumatology Reports, June 2010, p. 192–197; "Cutaneous manifestations of dermatomyositis and their management", Current Rheumatology Reports, June 2010, p. 192–197; "The skin in autoimmune diseases-Unmet needs", Autoimmunity Reviews, October 2016, p. 948–954 (original not read by us) en.wikipedia.org
- "Polymyositis and Dermatomyositis – Musculoskeletal and Connective Tissue Disorders", Merck Manuals Professional Edition, June 2013. facts only, no text reused. merckmanuals.com
- Wikipedia, "Dermatomyositis" (CC BY-SA 4.0), which cites: "Inflammatory muscle diseases", The New England Journal of Medicine, April 2015, p. 1734–1747; "Inflammatory muscle diseases", The New England Journal of Medicine, April 2015, p. 1734–1747 (original not read by us) en.wikipedia.org
- Wikipedia, "Dermatomyositis" (CC BY-SA 4.0), which cites: Selva-O'Callaghan, "Classification and management of adult inflammatory myopathies", The Lancet. Neurology, September 2018, p. 816–828; "Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches", Italian Journal of Dermatology and Venereology, April 2023, p. 84–98 (original not read by us) en.wikipedia.org
- Wikipedia, "Dermatomyositis" (CC BY-SA 4.0), which cites: "Polymyositis and Dermatomyositis – Musculoskeletal and Connective Tissue Disorders", Merck Manuals Professional Edition, June 2013 (we also read that source) en.wikipedia.org
Each numbered sentence above was checked against the source it cites before publication. Sentences citing Wikipedia adapt text from the English Wikipedia article Dermatomyositis (contributors), used under CC BY-SA 4.0; this entry is available under the same licence. Other sources were used for facts only; no text or images are copied from them.
More in Steroid-responsive Inflammatory Conditions
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced
